Literature DB >> 33663101

The usefulness of a three-dimensional printed segmental scapula prosthesis for recovering shoulder function in a patient with scapula chondrosarcoma: A case report.

Jong Hoon Park1, Hae Woon Jung2, Woo Young Jang1.   

Abstract

RATIONALE: Localized chondrosarcoma of the scapula has a favorable long-term survival outcome. Therefore, recovery of shoulder function after surgery is important in middle-aged patients. Currently, three-dimensional (3-D) printing implants can be applied for personalized limb salvage surgery. PATIENT CONCERNS: A 41-year-old woman with a palpable scapular area presented with shoulder pain for 3 months, which was aggravated during shoulder exercise. DIAGNOSES: Chondrosarcoma at left scapular (Malawer S1, Enniking II B, and grade II chondrosarcoma).
INTERVENTIONS: Wide excision for a localized chondrosarcoma at the infrascapular lesion was performed and the resected muscles around the scapula were repaired with a 3-D printed segmental scapula prosthesis for recovery of shoulder function. OUTCOMES: The affected shoulder achieved satisfactory function after operation using the 3-D printed segmental scapula prosthesis at 1 year 6 months after the operation. LESSONS: The 3-D printed segmental scapula prosthesis is a useful method for shoulder functional recovery in patients with scapula chondrosarcoma.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33663101      PMCID: PMC7909143          DOI: 10.1097/MD.0000000000024817

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  14 in total

1.  A new surgical classification system for shoulder-girdle resections. Analysis of 38 patients.

Authors:  M M Malawer; I Meller; W K Dunham
Journal:  Clin Orthop Relat Res       Date:  1991-06       Impact factor: 4.176

2.  One-step reconstruction with a 3D-printed, biomechanically evaluated custom implant after complex pelvic tumor resection.

Authors:  K C Wong; S M Kumta; N V Geel; J Demol
Journal:  Comput Aided Surg       Date:  2015-08-20

3.  Shoulder muscle endurance: the development of a standardized and reliable protocol.

Authors:  Jean-Sébastien Roy; Bryan Ma; Joy C Macdermid; Linda J Woodhouse
Journal:  Sports Med Arthrosc Rehabil Ther Technol       Date:  2011-01-11

4.  Chondrosarcoma of the scapula: long-term oncologic outcome.

Authors:  Rajeev Pant; Alan W Yasko; Valerae O Lewis; Kevin Raymond; Patrick P Lin
Journal:  Cancer       Date:  2005-07-01       Impact factor: 6.860

5.  Changes in strength, endurance, and fatigue during a resistance-training program for the triceps brachii muscle.

Authors:  Jelena Z Popadic Gacesa; Aleksandar V Klasnja; Nikola G Grujic
Journal:  J Athl Train       Date:  2013-08-05       Impact factor: 2.860

6.  Intralesional Versus Wide Resection of Low-Grade Chondrosarcomas of the Hand.

Authors:  Juan González Del Pino; Santiago A Lozano Calderón; Ivan Chebib; Jesse B Jupiter
Journal:  J Hand Surg Am       Date:  2016-01-21       Impact factor: 2.230

7.  Functional Results and Emotional Acceptance after Scapulectomy for Malignant Shoulder Tumors.

Authors:  Song-Feng Xu; Xiu-Chun Yu; Ming Xu; Yong-Cheng Hu; Xiao-Ping Liu
Journal:  Orthop Surg       Date:  2016-05       Impact factor: 2.071

8.  Three-dimensional printed calcaneal prosthesis following total calcanectomy.

Authors:  Jungo Imanishi; Peter F M Choong
Journal:  Int J Surg Case Rep       Date:  2015-03-10

9.  Application of 3D-printed PEEK scapula prosthesis in the treatment of scapular benign fibrous histiocytoma: A case report.

Authors:  Dong Liu; Jun Fu; Hongbin Fan; Dichen Li; Enchun Dong; Xin Xiao; Ling Wang; Zheng Guo
Journal:  J Bone Oncol       Date:  2018-08-02       Impact factor: 4.072

10.  Application of a three-dimensional printed segmental scapula prosthesis in the treatment of scapula tumors.

Authors:  Linglong Deng; Xing Zhao; Chi Wei; Wenqiang Qu; Li Yu; Shaobo Zhu
Journal:  J Int Med Res       Date:  2019-10-03       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.